These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24876097)

  • 1. Non-invasive vulnerable plaque imaging: how do we know that treatment works?
    Sannino A; Brevetti L; Giugliano G; Scudiero F; Toscano E; Mainolfi C; Cuocolo A; Perrino C; Stabile E; Trimarco B; Esposito G
    Eur Heart J Cardiovasc Imaging; 2014 Nov; 15(11):1194-202. PubMed ID: 24876097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Imaging of vulnerable plaque].
    Guagliumi G; Musumeci G; Pierli C; Fineschi M; Musuraca AC
    G Ital Cardiol (Rome); 2010 Dec; 11(12 Suppl 3):16S-21S. PubMed ID: 21491735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Detection and Treatment of the Vulnerable Coronary Plaque: Can We Prevent Acute Coronary Syndromes?
    Bom MJ; van der Heijden DJ; Kedhi E; van der Heyden J; Meuwissen M; Knaapen P; Timmer SAJ; van Royen N
    Circ Cardiovasc Imaging; 2017 May; 10(5):. PubMed ID: 28483945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The vulnerable coronary plaque: update on imaging technologies.
    Rosa GM; Bauckneht M; Masoero G; Mach F; Quercioli A; Seitun S; Balbi M; Brunelli C; Parodi A; Nencioni A; Vuilleumier N; Montecucco F
    Thromb Haemost; 2013 Oct; 110(4):706-22. PubMed ID: 23803753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Advances in the Diagnostic Imaging of Atherosclerosis: Insights into the Pathophysiology of Vulnerable Plaque.
    Mushenkova NV; Summerhill VI; Zhang D; Romanenko EB; Grechko AV; Orekhov AN
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive imaging of vulnerable plaques by molecular targeting of oxidized LDL with tagged oxidation-specific antibodies.
    Tsimikas S; Shaw PX
    J Cell Biochem Suppl; 2002; 39():138-46. PubMed ID: 12552613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detecting the vulnerable plaque in patients.
    Gonçalves I; den Ruijter H; Nahrendorf M; Pasterkamp G
    J Intern Med; 2015 Nov; 278(5):520-30. PubMed ID: 26306911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vulnerable plaque detection: an unrealistic quest or a feasible objective with a clinical value?
    Bourantas CV; Garcia-Garcia HM; Torii R; Zhang YJ; Westwood M; Crake T; Serruys PW
    Heart; 2016 Apr; 102(8):581-9. PubMed ID: 26783236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging the vulnerable plaque.
    Vancraeynest D; Pasquet A; Roelants V; Gerber BL; Vanoverschelde JL
    J Am Coll Cardiol; 2011 May; 57(20):1961-79. PubMed ID: 21565634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive or non-invasive imaging for detecting high-risk coronary lesions?
    Patel K; Tarkin J; Serruys PW; Tenekecioglu E; Foin N; Zhang YJ; Crake T; Moon J; Mathur A; Bourantas CV
    Expert Rev Cardiovasc Ther; 2017 Mar; 15(3):165-179. PubMed ID: 28256179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Clinical Value of High-Intensity Signals on the Coronary Atherosclerotic Plaques: Noncontrast T1-Weighted Magnetic Resonance Imaging.
    Ehara S; Matsumoto K; Shimada K
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The vulnerable plaque: current concepts and future perspectives on coronary morphology, composition and wall stress imaging.
    Silva Marques J; Pinto FJ
    Rev Port Cardiol; 2014 Feb; 33(2):101-10. PubMed ID: 24513090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive imaging of plaque vulnerability: an important tool for the assessment of agents to stabilise atherosclerotic plaques.
    Sosnovik DE; Muller JE; Kathiresan S; Brady TJ
    Expert Opin Investig Drugs; 2002 May; 11(5):693-704. PubMed ID: 11996650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The myth of the "vulnerable plaque": transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment.
    Arbab-Zadeh A; Fuster V
    J Am Coll Cardiol; 2015 Mar; 65(8):846-855. PubMed ID: 25601032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of coronary atherosclerosis: Current evidence and future perspectives.
    Koskinas KC; Windecker S; Räber L
    Trends Cardiovasc Med; 2016 Feb; 26(2):150-61. PubMed ID: 26089122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vulnerable plaque: definition, diagnosis, and treatment.
    Moreno PR
    Cardiol Clin; 2010 Feb; 28(1):1-30. PubMed ID: 19962047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary calcification identifies the vulnerable patient rather than the vulnerable Plaque.
    Mauriello A; Servadei F; Zoccai GB; Giacobbi E; Anemona L; Bonanno E; Casella S
    Atherosclerosis; 2013 Jul; 229(1):124-9. PubMed ID: 23578355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do plaques rapidly progress prior to myocardial infarction? The interplay between plaque vulnerability and progression.
    Ahmadi A; Leipsic J; Blankstein R; Taylor C; Hecht H; Stone GW; Narula J
    Circ Res; 2015 Jun; 117(1):99-104. PubMed ID: 26089367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG-PET imaging of atherosclerosis: Do we know what we see?
    Sheikine Y; Akram K
    Atherosclerosis; 2010 Aug; 211(2):371-80. PubMed ID: 20202637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early detection and invasive passivation of future culprit lesions: a future potential or an unrealistic pursuit of chimeras?
    Bourantas CV; Garcia-Garcia HM; Diletti R; Muramatsu T; Serruys PW
    Am Heart J; 2013 Jun; 165(6):869-881.e4. PubMed ID: 23708157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.